Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novogen Ltd (NASDAQ:NVGN)

1.96
Delayed Data
As of Feb 05
 +0.029 / +1.50%
Today’s Change
1.84
Today|||52-Week Range
9.50
-6.22%
Year-to-Date
No recent news for Novogen Ltd.

Today’s Trading

Previous close1.93
Today’s open2.03
Day’s range1.95 - 2.05
Volume14,167
Average volume (3 months)57,365
Market cap$33.3M
Dividend yield--
Data as of 02/05/2016

Growth & Valuation

Earnings growth (last year)+42.50%
Earnings growth (this year)+12.09%
Earnings growth (next 5 years)+4.00%
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book1.00

Competitors

 Today’s
change
Today’s
% change
PARNParnell Pharmaceutic...+0.03+1.21%
ABIOARCA Biopharma Inc-0.15-3.95%
PPHMPPeregrine Pharmaceut...-0.64-3.01%
OGENOragenics Inc-0.02-2.08%
Data as of 02/05/2016

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$0.00
Annual profit (last year)-$5.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
James Garner
COO, Head-Administration &
Finance
Cristyn Humphreys
Corporate headquarters
Hornsby, New South Wales (nsw)

Forecasts

Partner Offers